DCF — OCHSNER LSU HEALTH MONROE
Enterprise Value: $-75.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-75.2M
Enterprise Value
$-25.2M
PV of Cash Flows
$-50.1M
PV of Terminal Value
$-80.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $87.6M | $-3.9M | -4.0% | $-7.7M | $-7.0M |
| Year 2 | $90.3M | $-3.2M | -3.0% | $-7.0M | $-5.8M |
| Year 3 | $93.0M | $-2.3M | -2.0% | $-6.3M | $-4.7M |
| Year 4 | $95.8M | $-1.9M | -2.0% | $-6.0M | $-4.1M |
| Year 5 | $98.6M | $-1.7M | -2.0% | $-5.9M | $-3.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-75.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$85.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999647381266
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5